Curcumin affords neuroprotection and inhibits α-synuclein aggregation in lipopolysaccharide-induced Parkinson's disease model

Journal: Inflammopharmacology Publication Year: 2018 Authors: Sharma N., Nehru B. Study Type: Preclinical — In vivo (rat) PMID: 29027056 | Link: View on PubMed

Sep 19, 2026 | 1 min read

Research Gist

This study used an LPS-induced rat model, which produces Parkinson's-like changes by triggering sustained neuroinflammation rather than direct chemical toxicity. Rats treated with curcumin showed several measurable differences from untreated animals. Alpha-synuclein aggregation, the protein clumping characteristic of Parkinson's pathology, was reduced. NF-κB signalling and pro-inflammatory cytokine levels both fell. The study also found that curcumin prevented iron deposition in dopaminergic neurons — excess iron accumulation in this brain region is an observed feature in Parkinson's and contributes to oxidative damage.

Key Learnings

  • Alpha-synuclein aggregation was reduced in treated animals.
  • NF-κB signalling and pro-inflammatory cytokines both decreased.
  • Iron deposition in dopaminergic neurons was prevented.
  • The LPS model works through neuroinflammation rather than direct chemical toxicity.
  • This was a rat study — the same outcomes have not been shown in people.